Organotypic models in drug development / Monika Schäfer-Korting, Silvya Stuchi Maria-Engler, Robert Landsiedel.
Schäfer-Korting, Monika, 1952- editor.; Stuchi Maria-Engler, Silvya, editor.; Landsiedel, Robert, editor.
2021
RM301.25
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Organotypic models in drug development / Monika Schäfer-Korting, Silvya Stuchi Maria-Engler, Robert Landsiedel.
ISBN 9783030700638 (electronic bk.)
3030700631 (electronic bk.)
9783030700645 (print)
303070064X
9783030700652 (print)
3030700658
3030700623
9783030700621
DOI https://doi.org/10.1007/978-3-030-70063-8
Published Cham, Switzerland : Springer, [2021]
Language English
Description 1 online resource (viii, 323 pages) : illustrations (some color)
Item Number 10.1007/978-3-030-70063-8 doi
Call Number RM301.25
Dewey Decimal Classification 615.1/9
Summary This book provides latest findings in organotypic models in drug development and provides the scientific resonance needed in an emerging field of research in disciplines, such as molecular medicine, physiology, and pathophysiology. Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.
Bibliography, etc. Note Includes bibliographical references.
Access Note Access limited to authorized users.
Digital File Characteristics text file
PDF
Source of Description Online resource; title from PDF title page (SpringerLink, viewed April 15, 2021).
Added Author Schäfer-Korting, Monika, 1952- editor.
Stuchi Maria-Engler, Silvya, editor.
Landsiedel, Robert, editor.
Series Handbook of experimental pharmacology ; v. 265. 0171-2004
Available in Other Form Print version: 9783030700621
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh
How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development
Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future Development
In Vitro Models of the Blood-Brain Barrier
Neural In Vitro Models for Studying Substances Acting on the Central Nervous System
Engineered Heart Muscle Models in Phenotypic Drug Screens
Disease Models: Lung Models for Testing Drugs Against Inflammation and Infection
Skin Disease Models In Vitro and Inflammatory Mechanisms: Predictability for Drug Development
Immunocompetent Human Intestinal Models in Preclinical Drug Development
Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling
Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development
The CAM Assay as an Alternative In Vivo Model for Drug Testing.

Browse Subjects

Show more subjects...

Statistics

from
to
Export